|
HAMADA Hiromichi
Department School of Medicine(Yachiyo Medical Center), School of Medicine Position |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Efficacy of primary treatment with immunoglobulin plus cyclosporine for prevention of coronary artery abnormalities in Kawasaki disease patients predicted to be at increased risk of IVIG non-response (KAICA study): a controlled, phase 3, randomised, open-label, blinded-endpoints trial |
| Journal | Formal name：Lancet Abbreviation：Lancet ISSN code：01406736/1474547X |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 393(10176),pp.1128-1137 |
| Author and coauthor | Hamada Hiromichi |
| Authorship | Lead author |
| Publication date | 2019/03 |
| DOI | 10.1016/S0140-6736(18)32003-8 |